Cargando…

Risk, Outcomes, and Trends of Clostridium Difficile Infection in Multiple Myeloma Patients from a Nationwide Analysis

Background: Patients hospitalized with hematologic malignancy are particularly vulnerable to infection. We sought to determine the risk of Clostridium difficile infection (CDI) in hospitalization with multiple myeloma (MM), as well as its outcomes and trends, using a nationally representative databa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ran-Castillo, Dan, Oluwole, Adegbala, Abuaisha, Munder, Banks Paulino, Angela R, Alkhatatneh, Ahmad, Jang, Jeehoon, Donaldson, Sahai, Shammash, Jonathan, Williams, Karlene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561517/
https://www.ncbi.nlm.nih.gov/pubmed/31205828
http://dx.doi.org/10.7759/cureus.4391
_version_ 1783426140737634304
author Ran-Castillo, Dan
Oluwole, Adegbala
Abuaisha, Munder
Banks Paulino, Angela R
Alkhatatneh, Ahmad
Jang, Jeehoon
Donaldson, Sahai
Shammash, Jonathan
Williams, Karlene
author_facet Ran-Castillo, Dan
Oluwole, Adegbala
Abuaisha, Munder
Banks Paulino, Angela R
Alkhatatneh, Ahmad
Jang, Jeehoon
Donaldson, Sahai
Shammash, Jonathan
Williams, Karlene
author_sort Ran-Castillo, Dan
collection PubMed
description Background: Patients hospitalized with hematologic malignancy are particularly vulnerable to infection. We sought to determine the risk of Clostridium difficile infection (CDI) in hospitalization with multiple myeloma (MM), as well as its outcomes and trends, using a nationally representative database. Methods: The Nationwide Inpatient Sample (NIS) from January 2010 to September 2015 was used for this study. We identified all patients aged 18 years or older with a diagnosis of MM using the International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) codes. We identified trends in the annual rates of CDI in MM using negative binomial regressions with robust error variance. We conducted multivariate logistic regression to determine the incidence and the associated risk factors of CDI in MM and compared the outcomes between those with and without CDI using the propensity score method inverse probability weighting to adjust for baseline covariates. Results: In our cohort study of 114,249 MM patients, 45.96% were females and 54.04% were males. CDI was present in 3.1% of the MM patients. The number of CDI cases increased over the study period with an average rate of 3.27% per year. The mortality rate decreased over the same period with an average rate of 10% decrease per year. Hematopoietic stem cell transplantation (HSCT), neutropenia, inflammatory disease, atrial fibrillation (AF), and chronic kidney disease (CKD) were significant associated risk factors of CDI in MM patients. After adjusting for covariates, patients with CDI had a prolonged hospital stay, inpatient mortality, and significantly increased odds of acute kidney injury (AKI) and AKI requiring hemodialysis, along with higher healthcare resources utilization with significantly higher hospital costs. Conclusion: MM patients with CDI have significantly increased odds of inpatient mortality, AKI, and AKI requiring hemodialysis. They also have increased healthcare resource utilization compared with those without CDI. Despite the increased rate of the CDI over the years, the mortality rate is going down.
format Online
Article
Text
id pubmed-6561517
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-65615172019-06-14 Risk, Outcomes, and Trends of Clostridium Difficile Infection in Multiple Myeloma Patients from a Nationwide Analysis Ran-Castillo, Dan Oluwole, Adegbala Abuaisha, Munder Banks Paulino, Angela R Alkhatatneh, Ahmad Jang, Jeehoon Donaldson, Sahai Shammash, Jonathan Williams, Karlene Cureus Internal Medicine Background: Patients hospitalized with hematologic malignancy are particularly vulnerable to infection. We sought to determine the risk of Clostridium difficile infection (CDI) in hospitalization with multiple myeloma (MM), as well as its outcomes and trends, using a nationally representative database. Methods: The Nationwide Inpatient Sample (NIS) from January 2010 to September 2015 was used for this study. We identified all patients aged 18 years or older with a diagnosis of MM using the International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) codes. We identified trends in the annual rates of CDI in MM using negative binomial regressions with robust error variance. We conducted multivariate logistic regression to determine the incidence and the associated risk factors of CDI in MM and compared the outcomes between those with and without CDI using the propensity score method inverse probability weighting to adjust for baseline covariates. Results: In our cohort study of 114,249 MM patients, 45.96% were females and 54.04% were males. CDI was present in 3.1% of the MM patients. The number of CDI cases increased over the study period with an average rate of 3.27% per year. The mortality rate decreased over the same period with an average rate of 10% decrease per year. Hematopoietic stem cell transplantation (HSCT), neutropenia, inflammatory disease, atrial fibrillation (AF), and chronic kidney disease (CKD) were significant associated risk factors of CDI in MM patients. After adjusting for covariates, patients with CDI had a prolonged hospital stay, inpatient mortality, and significantly increased odds of acute kidney injury (AKI) and AKI requiring hemodialysis, along with higher healthcare resources utilization with significantly higher hospital costs. Conclusion: MM patients with CDI have significantly increased odds of inpatient mortality, AKI, and AKI requiring hemodialysis. They also have increased healthcare resource utilization compared with those without CDI. Despite the increased rate of the CDI over the years, the mortality rate is going down. Cureus 2019-04-05 /pmc/articles/PMC6561517/ /pubmed/31205828 http://dx.doi.org/10.7759/cureus.4391 Text en Copyright © 2019, Ran-Castillo et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Ran-Castillo, Dan
Oluwole, Adegbala
Abuaisha, Munder
Banks Paulino, Angela R
Alkhatatneh, Ahmad
Jang, Jeehoon
Donaldson, Sahai
Shammash, Jonathan
Williams, Karlene
Risk, Outcomes, and Trends of Clostridium Difficile Infection in Multiple Myeloma Patients from a Nationwide Analysis
title Risk, Outcomes, and Trends of Clostridium Difficile Infection in Multiple Myeloma Patients from a Nationwide Analysis
title_full Risk, Outcomes, and Trends of Clostridium Difficile Infection in Multiple Myeloma Patients from a Nationwide Analysis
title_fullStr Risk, Outcomes, and Trends of Clostridium Difficile Infection in Multiple Myeloma Patients from a Nationwide Analysis
title_full_unstemmed Risk, Outcomes, and Trends of Clostridium Difficile Infection in Multiple Myeloma Patients from a Nationwide Analysis
title_short Risk, Outcomes, and Trends of Clostridium Difficile Infection in Multiple Myeloma Patients from a Nationwide Analysis
title_sort risk, outcomes, and trends of clostridium difficile infection in multiple myeloma patients from a nationwide analysis
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561517/
https://www.ncbi.nlm.nih.gov/pubmed/31205828
http://dx.doi.org/10.7759/cureus.4391
work_keys_str_mv AT rancastillodan riskoutcomesandtrendsofclostridiumdifficileinfectioninmultiplemyelomapatientsfromanationwideanalysis
AT oluwoleadegbala riskoutcomesandtrendsofclostridiumdifficileinfectioninmultiplemyelomapatientsfromanationwideanalysis
AT abuaishamunder riskoutcomesandtrendsofclostridiumdifficileinfectioninmultiplemyelomapatientsfromanationwideanalysis
AT bankspaulinoangelar riskoutcomesandtrendsofclostridiumdifficileinfectioninmultiplemyelomapatientsfromanationwideanalysis
AT alkhatatnehahmad riskoutcomesandtrendsofclostridiumdifficileinfectioninmultiplemyelomapatientsfromanationwideanalysis
AT jangjeehoon riskoutcomesandtrendsofclostridiumdifficileinfectioninmultiplemyelomapatientsfromanationwideanalysis
AT donaldsonsahai riskoutcomesandtrendsofclostridiumdifficileinfectioninmultiplemyelomapatientsfromanationwideanalysis
AT shammashjonathan riskoutcomesandtrendsofclostridiumdifficileinfectioninmultiplemyelomapatientsfromanationwideanalysis
AT williamskarlene riskoutcomesandtrendsofclostridiumdifficileinfectioninmultiplemyelomapatientsfromanationwideanalysis